Krolewski A S, Fogarty D G, Warram J H
Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA 02215, USA.
Diabetes Res Clin Pract. 1998 Apr;39 Suppl:S1-14. doi: 10.1016/s0168-8227(98)00015-1.
Prolonged duration of diabetes mellitus, poor long term glycemic control and raised blood pressure have all been clearly related to the development of diabetic nephropathy. Evidence exists to suggest that a subset of individuals with diabetes have a genetic predisposition to diabetic nephropathy. Cases of diabetic nephropathy cluster in families and a parental history of hypertension is more common in patients with diabetic nephropathy. Current evidence suggests an important role for hypertension in the genetic susceptibility to diabetic nephropathy but the extent of this is unknown. While cellular and animal studies have generated a plethora of data regarding mechanisms involved in the role of hypertension and diabetic nephropathy, these are not helpful for drawing conclusions in humans. In the following review, we examine the available clinical, epidemiologic and family studies to assess the relationship between the development of hypertension and diabetic nephropathy in IDDM and NIDDM. We will demonstrate the differences in the epidemiology of hypertension in diabetes depending on the type of diabetes and thus, move the emphasis of nephropathy susceptibility away from hypertension per se. We hope to emphasize instead the homogeneity of nephropathy risk in both IDDM and NIDDM and also the idea that a common genetic susceptibility exists for all types of diabetes and is conditional on cumulative exposure to hyperglycemia. Regarding the interaction of hypertension and nephropathy in diabetes mellitus, any conclusions at this time about what is inherited and what is acquired must be regarded as speculative. However we will discuss some potential mechanisms of hypertension in the evolution of nephropathy and we will allude to the role for novel genetic studies in the search for nephropathy susceptibility gene(s).
糖尿病病程延长、长期血糖控制不佳以及血压升高均与糖尿病肾病的发生明显相关。有证据表明,一部分糖尿病患者具有糖尿病肾病的遗传易感性。糖尿病肾病病例在家族中呈聚集性,糖尿病肾病患者中父母有高血压病史的情况更为常见。目前的证据表明高血压在糖尿病肾病的遗传易感性中起重要作用,但具体程度尚不清楚。虽然细胞和动物研究已经产生了大量关于高血压和糖尿病肾病作用机制的数据,但这些对得出人类相关结论并无帮助。在以下综述中,我们将研究现有的临床、流行病学和家族研究,以评估1型糖尿病和2型糖尿病中高血压的发生与糖尿病肾病之间的关系。我们将证明糖尿病中高血压的流行病学差异取决于糖尿病的类型,从而将肾病易感性的重点从高血压本身转移。我们希望强调的是,1型糖尿病和2型糖尿病中肾病风险的同质性,以及所有类型糖尿病都存在共同的遗传易感性且取决于高血糖累积暴露的观点。关于糖尿病中高血压与肾病的相互作用,目前关于遗传因素和后天因素的任何结论都必须被视为推测性的。然而,我们将讨论高血压在肾病发展中的一些潜在机制,并提及新型基因研究在寻找肾病易感基因方面的作用。